Literature DB >> 33390994

COVID-19 Disease and Vitamin D: A Mini-Review.

Mohamed Said Boulkrane1, Victoria Ilina1, Roman Melchakov1, Julia Fedotova2,3, Filippo Drago4, Lucia Gozzo4, Undurti Narasimha Das5, A M Abd El-Aty6,7, Denis Baranenko1.   

Abstract

Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19.
Copyright © 2020 Boulkrane, Ilina, Melchakov, Fedotova, Drago, Gozzo, Das, Abd El-Aty and Baranenko.

Entities:  

Keywords:  COVID 19; SARS-CoV-2; respiratory tract infection; vitamin D3; vitamin D3 receptor

Year:  2020        PMID: 33390994      PMCID: PMC7773655          DOI: 10.3389/fphar.2020.604579

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  5 in total

1.  Co-administration of vitamin D3 and Lacticaseibacillus paracasei DG increase 25-hydroxyvitamin D serum levels in mice.

Authors:  Ignazio Castagliuolo; Melania Scarpa; Paola Brun; Giulia Bernabe; Valeria Sagheddu; Marina Elli; Walter Fiore; Valerio De Vitis; Simone Guglielmetti
Journal:  Ann Microbiol       Date:  2021-10-18       Impact factor: 3.168

2.  Vitamin D status is not associated with clinical severity of COVID-19 in pregnant women.

Authors:  Arzu Bilge Tekin; Murat Yassa; Pınar Birol; Sakine Nisa Unlu; Turan Sahin; Ayca Miray Buran; Esra Ayanoglu; Niyazi Tug
Journal:  Eur J Nutr       Date:  2021-10-28       Impact factor: 4.865

3.  Potential of Vitamin D Food Fortification in Prevention of Cancer Deaths-A Modeling Study.

Authors:  Tobias Niedermaier; Thomas Gredner; Sabine Kuznia; Ben Schöttker; Ute Mons; Hermann Brenner
Journal:  Nutrients       Date:  2021-11-09       Impact factor: 5.717

4.  Vitamin D Status and SARS-CoV-2 Infection in a Cohort of Kidney Transplanted Patients.

Authors:  Anna Regalia; Matteo Benedetti; Silvia Malvica; Carlo Alfieri; Mariarosaria Campise; Donata Cresseri; Maria Teresa Gandolfo; Federica Tripodi; Giuseppe Castellano; Piergiorgio Messa
Journal:  Nutrients       Date:  2022-01-13       Impact factor: 5.717

Review 5.  Nutritional Impact and Its Potential Consequences on COVID-19 Severity.

Authors:  Esmaeil Mortaz; Gillina Bezemer; Shamila D Alipoor; Mohammad Varahram; Sharon Mumby; Gert Folkerts; Johan Garssen; Ian M Adcock
Journal:  Front Nutr       Date:  2021-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.